These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24194752)

  • 1. Expression of Potential Cancer Stem Cell Marker ABCG2 is Associated with Malignant Behaviors of Hepatocellular Carcinoma.
    Zhang G; Wang Z; Luo W; Jiao H; Wu J; Jiang C
    Gastroenterol Res Pract; 2013; 2013():782581. PubMed ID: 24194752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.
    Hou H; Sun H; Lu P; Ge C; Zhang L; Li H; Zhao F; Tian H; Zhang L; Chen T; Yao M; Li J
    Mol Cancer Ther; 2013 Dec; 12(12):2874-84. PubMed ID: 24130050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions.
    Sasaki N; Ishiwata T; Hasegawa F; Michishita M; Kawai H; Matsuda Y; Arai T; Ishikawa N; Aida J; Takubo K; Toyoda M
    Cancer Sci; 2018 Apr; 109(4):1135-1146. PubMed ID: 29444383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma.
    Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
    Wang M; Wang Z; Zhi X; Ding W; Xiong J; Tao T; Yang Y; Zhang H; Zi X; Zhou W; Huang G
    Biomed Pharmacother; 2020 Sep; 129():110315. PubMed ID: 32554246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma.
    Sukowati CH; Rosso N; Pascut D; Anfuso B; Torre G; Francalanci P; Crocè LS; Tiribelli C
    BMC Gastroenterol; 2012 Nov; 12():160. PubMed ID: 23153066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients.
    Chen YL; Chen PM; Lin PY; Hsiau YT; Chu PY
    Anticancer Res; 2016 Jun; 36(6):2983-8. PubMed ID: 27272814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression].
    Balcik-Ercin P; Cetin M; Yalim-Camci I; Uygur T; Yagci T
    Mol Biol (Mosk); 2020; 54(1):87-94. PubMed ID: 32163392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling.
    Hu C; Li H; Li J; Zhu Z; Yin S; Hao X; Yao M; Zheng S; Gu J
    Carcinogenesis; 2008 Dec; 29(12):2289-97. PubMed ID: 18820285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma.
    Zen Y; Fujii T; Yoshikawa S; Takamura H; Tani T; Ohta T; Nakanuma Y
    Am J Pathol; 2007 May; 170(5):1750-62. PubMed ID: 17456779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin enhances the sensitivity of hepatocellular carcinoma side population cells to doxorubicin via miR-491/ABCG2.
    Xie ZY; Liu MS; Zhang C; Cai PC; Xiao ZH; Wang FF
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30120100
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
    Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
    Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
    Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
    Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells.
    Murakami K; Umemura N; Adachi M; Motoki M; Ohkoshi E
    Exp Ther Med; 2022 Dec; 24(6):722. PubMed ID: 36340608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.
    Wang XQ; Ongkeko WM; Chen L; Yang ZF; Lu P; Chen KK; Lopez JP; Poon RT; Fan ST
    Hepatology; 2010 Aug; 52(2):528-39. PubMed ID: 20683952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive Disorder promotes Hepatocellular Carcinoma metastasis via upregulation of ABCG2 gene expression and maintenance of self-renewal.
    Hu H; Luo SJ; Cao ZR; Wu Y; Mo Z; Wang Y; Yu L; Chen Y; Xu L; Zhang SJ
    J Cancer; 2020; 11(18):5309-5317. PubMed ID: 32742477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q; Zhang X; Deng T; Gao J
    Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.
    Huber S; Wege AK; Bernhardt G; Buschauer A; Brockhoff G
    Cytometry A; 2015 Aug; 87(8):707-16. PubMed ID: 25892097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
    Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.